Physiologic subtypes of gestational glucose intolerance and risk of future maternal prediabetes or diabetes
BACKGROUND: Gestational glucose intolerance (GGI), an abnormal initial gestational diabetes (GDM) screening test, conveys an increased risk of future diabetes, even when GDM is not present. We aimed to determine if GGI subtypes, classified according to the underlying mechanism of hyperglycemia, are at differential risk for future prediabetes or diabetes. METHODS: We defined GGI as glucose loading test 1-hour glucose ≥ 140 mg/dL at > 22 weeks' gestation with a subsequent oral glucose tolerance test that did not meet criteria for GDM diagnosis. We applied homeostasis model assessment (HOMA-2) to fasting glucose and insulin at 16-20 weeks' gestation and classified pregnancies with GGI into subtypes based on whether they had insulin resistance (HOMA-2S <50th percentile), insulin deficiency (HOMA-2B <50th percentile), or both (mixed). We assessed the future risk of prediabetes/diabetes (HbA1c ≥ 5.7% at ≥ 3 months after delivery) in each GGI subtype, compared to pregnancies with normal glucose tolerance, using covariate-adjusted Cox proportional hazards models. RESULTS: Of 747 pregnancies, there were 123 with GGI: 51.2% insulin resistant, 26.8% insulin deficient, 17.9% mixed, and 4.1% uncategorized. Over a median of 15.9 years of follow-up, 36.4% (N=272) developed prediabetes or diabetes. All GGI subtypes were associated with an increased risk of future prediabetes/diabetes compared to normal glucose tolerance controls: insulin resistant adjusted hazard ratio (aHR)=1.80 (95% confidence interval: 1.22-2.65, p=0.003), insulin deficient aHR=2.15 (1.35-3.42, p=0.001) and mixed aHR=2.07 (1.02-4.20, p=0.045). CONCLUSIONS: GGI confers an increased risk of future maternal prediabetes/diabetes, regardless of the mechanism underlying glucose intolerance during pregnancy.
Authors
- Daryl J. Selen (ORCID: https://orcid.org/0000-0001-8276-495X)
- Tanayott Thaweethai (ORCID: https://orcid.org/0000-0003-0613-4176)
- James B. Meigs (ORCID: https://orcid.org/0000-0002-2439-2657)
- Sarah C Hsu (ORCID: https://orcid.org/0000-0001-9823-9711)
- Diana C. Soria‐Contreras (ORCID: https://orcid.org/0000-0001-5783-5365)
- Jeffrey L. Ecker (ORCID: https://orcid.org/0000-0002-0088-5211)
- Deepti B. Pant (ORCID: https://orcid.org/0000-0002-6890-081X)
- Camille Elise Powe (ORCID: https://orcid.org/0000-0002-7060-7778)
- Kaitlyn E. James (ORCID: https://orcid.org/0000-0001-8849-1032)
Institutions
- Broad Institute (US)
- Harvard University (US)
- Brown University (US)
- Massachusetts General Hospital (US)
- Women & Infants Hospital of Rhode Island (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1210/clinem/dgag470
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00